Julia Krause
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julia Krause has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Tanja Zeller
German Centre of Cardiovascular Research (DZHK), Partner Site North, Germany (C.S., M.J., R.B.S., S.B., T.Z.).
3 shared publications - Christian Müller
Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (C.M.).
2 shared publications - Justus Stenzig
German Center for Cardiovascular Research (DZHK), Partner Site North, Hamburg, Germany
2 shared publications - Aaltje Maria Stella Stoter
Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf , Martinistrasse 52, 20246 Hamburg
1 shared publication - Alexander Zink
Department of Dermatology and Allergy, School of Medicine Technical University of Munich Munich Germany
1 shared publication Arne Hansen
Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf , Martinistrasse 52, 20246 Hamburg
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Optogenetic tachypacing facilitates burst-induced arrhythmia in stem cell-derived human atrial engineered heart tissue
Aims: Large animal models for atrial fibrillation (AF) research are ethically challenging and costly. Suitable humanized in vitro models could circumvent these problems. Here, we aimed to combine tissue engineering, human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCM), and optogenetic pacing to trigger an in vitro fibrillation-like state, which can be analysed by simple video recording. Methods and results: Atrial engineered heart tissue (aEHT) was created from hiPSC-aCM and transduced with adeno-associated virus vectors to express the channelrhodopsins CheRiff2.0, Chronos, or PsCatCh2.0f, respectively. We developed novel optogenetic hardware, based on microcontroller programmable light-emitting diodes. The interplay between aEHTs and hardware was optimized, and different pacing patterns were evaluated. Electrical burst pacing was evaluated for arrhythmia induction. Tissue constructs were analysed with regard to action potential, gene and protein expression, and structure. We found our optimized CheRiff2.0 best suitable for optogenetic pacing of aEHT at up to 5 Hz. Atrial EHT could be faithfully tachypaced at 4 Hz for 2.5 weeks. After 5 weeks, electrical burst pacing (20 Hz, 0.5 s) successfully induced self-sustained episodes of a state of fast beating, lower force, and incomplete relaxation. The propensity of these burst-evoked episodes of fibrillation was 3.2-fold higher in long-term paced aEHT than in non-paced controls. Action potential shape and gene expression recapitulated typical features of AF in the tachypaced aEHTs. Conclusion: We successfully created a first-of-its-kind in vitro model of AF, recapitulating the self-sustainability of atrial arrhythmia (‘AF begets AF’). Fibrillation-like episodes can be verified by visual inspection, rendering analysis possible without an electrophysiological setup.
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Open AccessOptogenetic tachypacing facilitates burst-induced arrhythmia in stem cell-derived human atrial engineered heart tissue
Aims: Large animal models for atrial fibrillation (AF) research are ethically challenging and costly. Suitable humanized in vitro models could circumvent these problems. Here, we aimed to combine tissue engineering, human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCM), and optogenetic pacing to trigger an in vitro fibrillation-like state, which can be analysed by simple video recording. Methods and results: Atrial engineered heart tissue (aEHT) was created from hiPSC-aCM and transduced with adeno-associated virus vectors to express the channelrhodopsins CheRiff2.0, Chronos, or PsCatCh2.0f, respectively. We developed novel optogenetic hardware, based on microcontroller programmable light-emitting diodes. The interplay between aEHTs and hardware was optimized, and different pacing patterns were evaluated. Electrical burst pacing was evaluated for arrhythmia induction. Tissue constructs were analysed with regard to action potential, gene and protein expression, and structure. We found our optimized CheRiff2.0 best suitable for optogenetic pacing of aEHT at up to 5 Hz. Atrial EHT could be faithfully tachypaced at 4 Hz for 2.5 weeks. After 5 weeks, electrical burst pacing (20 Hz, 0.5 s) successfully induced self-sustained episodes of a state of fast beating, lower force, and incomplete relaxation. The propensity of these burst-evoked episodes of fibrillation was 3.2-fold higher in long-term paced aEHT than in non-paced controls. Action potential shape and gene expression recapitulated typical features of AF in the tachypaced aEHTs. Conclusion: We successfully created a first-of-its-kind in vitro model of AF, recapitulating the self-sustainability of atrial arrhythmia (‘AF begets AF’). Fibrillation-like episodes can be verified by visual inspection, rendering analysis possible without an electrophysiological setup.
- Open Access
- 6 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (16) , 8468
Long-Chain Acyl-Carnitines Interfere with Mitochondrial ATP Production Leading to Cardiac Dysfunction in Zebrafish
In the human heart, the energy supplied by the production of ATP is predominately accomplished by ß-oxidation in mitochondria, using fatty acids (FAs) as the primary fuel. Long-chain acylcarnitines (LCACs) are intermediate forms of FA transport that are essential for FA delivery from the cytosol into mitochondria. Here, we analyzed the impact of the LCACs C18 and C18:1 on mitochondrial function and, subsequently, on heart functionality in the in vivo vertebrate model system of zebrafish (Danio rerio). Since LCACs are formed and metabolized in mitochondria, we assessed mitochondrial morphology, structure and density in C18- and C18:1-treated zebrafish and found no mitochondrial alterations compared to control-treated (short-chain acylcarnitine, C3) zebrafish embryos. However, mitochondrial function and subsequently ATP production was severely impaired in C18- and C18:1-treated zebrafish embryos. Furthermore, we found that C18 and C18:1 treatment of zebrafish embryos led to significantly impaired cardiac contractile function, accompanied by reduced heart rate and diminished atrial and ventricular fractional shortening, without interfering with cardiomyocyte differentiation, specification and growth. In summary, our findings provide insights into the direct role of long-chain acylcarnitines on vertebrate heart function by interfering with regular mitochondrial function and thereby energy allocation in cardiomyocytes.
- 6 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (16) , 8468
Open AccessLong-Chain Acyl-Carnitines Interfere with Mitochondrial ATP Production Leading to Cardiac Dysfunction in Zebrafish
In the human heart, the energy supplied by the production of ATP is predominately accomplished by ß-oxidation in mitochondria, using fatty acids (FAs) as the primary fuel. Long-chain acylcarnitines (LCACs) are intermediate forms of FA transport that are essential for FA delivery from the cytosol into mitochondria. Here, we analyzed the impact of the LCACs C18 and C18:1 on mitochondrial function and, subsequently, on heart functionality in the in vivo vertebrate model system of zebrafish (Danio rerio). Since LCACs are formed and metabolized in mitochondria, we assessed mitochondrial morphology, structure and density in C18- and C18:1-treated zebrafish and found no mitochondrial alterations compared to control-treated (short-chain acylcarnitine, C3) zebrafish embryos. However, mitochondrial function and subsequently ATP production was severely impaired in C18- and C18:1-treated zebrafish embryos. Furthermore, we found that C18 and C18:1 treatment of zebrafish embryos led to significantly impaired cardiac contractile function, accompanied by reduced heart rate and diminished atrial and ventricular fractional shortening, without interfering with cardiomyocyte differentiation, specification and growth. In summary, our findings provide insights into the direct role of long-chain acylcarnitines on vertebrate heart function by interfering with regular mitochondrial function and thereby energy allocation in cardiomyocytes.
- Open Access
Tissue-specific multiOMICs analysis of atrial fibrillation
Genome-wide association studies (GWAS) for atrial fibrillation (AF) have uncovered numerous disease-associated variants. Their underlying molecular mechanisms, especially consequences for mRNA and protein expression remain largely elusive. Thus, novel multiOMICs approaches are needed for deciphering the underlying molecular networks. Here, we integrated genomics, transcriptomics, and proteomics of human atrial tissue which allowed for identifying widespread effects of genetic variants on both transcript (cis eQTL) and protein (cis pQTL) abundance. We further established a novel targeted trans QTL approach based on polygenic risk scores to identify candidates for AF core genes. Using this approach, we identified two trans eQTLs and four trans pQTLs for AF GWAS hits, and elucidated the role of the transcription factor NKX2-5 as a link between the GWAS SNP rs9481842 and AF. Altogether, we present an integrative multiOMICs method to uncover trans-acting networks in small datasets and provide a rich resource of atrial tissue-specific regulatory variants for transcript and protein levels for cardiovascular disease gene prioritization.
Open AccessTissue-specific multiOMICs analysis of atrial fibrillation
Genome-wide association studies (GWAS) for atrial fibrillation (AF) have uncovered numerous disease-associated variants. Their underlying molecular mechanisms, especially consequences for mRNA and protein expression remain largely elusive. Thus, novel multiOMICs approaches are needed for deciphering the underlying molecular networks. Here, we integrated genomics, transcriptomics, and proteomics of human atrial tissue which allowed for identifying widespread effects of genetic variants on both transcript (cis eQTL) and protein (cis pQTL) abundance. We further established a novel targeted trans QTL approach based on polygenic risk scores to identify candidates for AF core genes. Using this approach, we identified two trans eQTLs and four trans pQTLs for AF GWAS hits, and elucidated the role of the transcription factor NKX2-5 as a link between the GWAS SNP rs9481842 and AF. Altogether, we present an integrative multiOMICs method to uncover trans-acting networks in small datasets and provide a rich resource of atrial tissue-specific regulatory variants for transcript and protein levels for cardiovascular disease gene prioritization.
- 17 September 2019
- Published by Georg Thieme Verlag KG in Das Gesundheitswesen
- Vol. 83 (01) , 53-58
Wie offen ist die bayerische Bevölkerung für Teledermatologie? Eine Querschnittsstudie in ländlichen und städtischen Regionen Bayerns
Zusammenfassung: Ziel der Studie Die Teledermatologie bietet Potenziale, um die dermatologische Versorgung in ländlichen Regionen zu verbessern. Ziel dieser Studie war es, die Nutzungsbereitschaft von Teledermatologie in der ländlichen Bevölkerung Bayerns zu erheben und Bedenken zu erfassen.Methodik Die Daten wurden im Rahmen einer Querschnittsstudie im Bayerischen Wald (Q1/2017) sowie einer Follow-up-Erhebung einer laufenden Kohortenstudie (Q1/2018) mithilfe standardisierter Papierfragebögen erhoben. Studienteilnehmer wurden gefragt, ob sie bereit wären, ihrem Dermatologen Fotos von „Hautausschlägen“ oder anderen Hautveränderungen über das Internet zu senden, und falls „nein“, warum nicht.Ergebnisse Insgesamt wurden Daten von 1 116 Personen mit Wohnsitz in Bayern ausgewertet (Altersdurchschnitt 50,2 Jahren, 57,3% weiblich, 80,4% mit Wohnsitz in ländlichen Landkreisen). Die Bereitschaft zur Nutzung von Teledermatologie in der Gesamtstichprobe lag bei 36,6%. Frauen, ältere Studienteilnehmer und Studienteilnehmer, die in ländlichen Regionen lebten, waren weniger offen für die Nutzung von Teledermatologie. Die häufigsten Bedenken gegenüber Teledermatologie waren Unpersönlichkeit, Zweifel an der Qualität der medizinischen Leistung sowie Bedenken hinsichtlich des Datenschutzes und der Privatsphäre.Schlussfolgerung Die Bereitschaft zur Nutzung von Teledermatologie in den ländlichen Regionen Bayerns ist bisher eher gering. Damit die Teledermatologie ihre Potenziale zur Verbesserung der medizinischen Versorgung voll entfalten könnte, wäre eine umfangreiche Aufklärung der ländlichen Bevölkerung über Funktionsweisen und die Möglichkeiten der Teledermatologie sowie eine Sicherstellung des Datenschutzes unerlässlich.
- 17 September 2019
- Published by Georg Thieme Verlag KG in Das Gesundheitswesen
- Vol. 83 (01) , 53-58
Wie offen ist die bayerische Bevölkerung für Teledermatologie? Eine Querschnittsstudie in ländlichen und städtischen Regionen Bayerns
Zusammenfassung: Ziel der Studie Die Teledermatologie bietet Potenziale, um die dermatologische Versorgung in ländlichen Regionen zu verbessern. Ziel dieser Studie war es, die Nutzungsbereitschaft von Teledermatologie in der ländlichen Bevölkerung Bayerns zu erheben und Bedenken zu erfassen.Methodik Die Daten wurden im Rahmen einer Querschnittsstudie im Bayerischen Wald (Q1/2017) sowie einer Follow-up-Erhebung einer laufenden Kohortenstudie (Q1/2018) mithilfe standardisierter Papierfragebögen erhoben. Studienteilnehmer wurden gefragt, ob sie bereit wären, ihrem Dermatologen Fotos von „Hautausschlägen“ oder anderen Hautveränderungen über das Internet zu senden, und falls „nein“, warum nicht.Ergebnisse Insgesamt wurden Daten von 1 116 Personen mit Wohnsitz in Bayern ausgewertet (Altersdurchschnitt 50,2 Jahren, 57,3% weiblich, 80,4% mit Wohnsitz in ländlichen Landkreisen). Die Bereitschaft zur Nutzung von Teledermatologie in der Gesamtstichprobe lag bei 36,6%. Frauen, ältere Studienteilnehmer und Studienteilnehmer, die in ländlichen Regionen lebten, waren weniger offen für die Nutzung von Teledermatologie. Die häufigsten Bedenken gegenüber Teledermatologie waren Unpersönlichkeit, Zweifel an der Qualität der medizinischen Leistung sowie Bedenken hinsichtlich des Datenschutzes und der Privatsphäre.Schlussfolgerung Die Bereitschaft zur Nutzung von Teledermatologie in den ländlichen Regionen Bayerns ist bisher eher gering. Damit die Teledermatologie ihre Potenziale zur Verbesserung der medizinischen Versorgung voll entfalten könnte, wäre eine umfangreiche Aufklärung der ländlichen Bevölkerung über Funktionsweisen und die Möglichkeiten der Teledermatologie sowie eine Sicherstellung des Datenschutzes unerlässlich.
- Open Access
- 20 August 2018
- Published by MDPI AG in Biomolecules
- Vol. 8 (3) , 74
Novel DNA Methylation Sites Influence GPR15 Expression in Relation to Smoking
Smoking is a major risk factor for cardiovascular diseases and has been implicated in the regulation of the G protein-coupled receptor 15 (GPR15) by affecting CpG methylation. The G protein-coupled receptor 15 is involved in angiogenesis and inflammation. An effect on GPR15 gene regulation has been shown for the CpG site CpG3.98251294. We aimed to analyze the effect of smoking on GPR15 expression and methylation sites spanning the GPR15 locus. DNA methylation of nine GPR15 CpG sites was measured in leukocytes from 1291 population-based individuals using the EpiTYPER. Monocytic GPR15 expression was measured by qPCR at baseline and five-years follow up. GPR15 gene expression was upregulated in smokers (beta (ß) = −2.699, p-value (p) = 1.02 × 10−77) and strongly correlated with smoking exposure (ß = −0.063, p = 2.95 × 10−34). Smoking cessation within five years reduced GPR15 expression about 19% (p = 9.65 × 10−5) with decreasing GPR15 expression over time (ß = 0.031, p = 3.81 × 10−6). Additionally, three novel CpG sites within GPR15 affected by smoking were identified. For CpG3.98251047, DNA methylation increased steadily after smoking cessation (ß = 0.123, p = 1.67 × 10−3) and strongly correlated with changes in GPR15 expression (ß = 0.036, p = 4.86 × 10−5). Three novel GPR15 CpG sites were identified in relation to smoking and GPR15 expression. Our results provide novel insights in the regulation of GPR15, which possibly linked smoking to inflammation and disease progression.
- 20 August 2018
- Published by MDPI AG in Biomolecules
- Vol. 8 (3) , 74
Open AccessNovel DNA Methylation Sites Influence GPR15 Expression in Relation to Smoking
Smoking is a major risk factor for cardiovascular diseases and has been implicated in the regulation of the G protein-coupled receptor 15 (GPR15) by affecting CpG methylation. The G protein-coupled receptor 15 is involved in angiogenesis and inflammation. An effect on GPR15 gene regulation has been shown for the CpG site CpG3.98251294. We aimed to analyze the effect of smoking on GPR15 expression and methylation sites spanning the GPR15 locus. DNA methylation of nine GPR15 CpG sites was measured in leukocytes from 1291 population-based individuals using the EpiTYPER. Monocytic GPR15 expression was measured by qPCR at baseline and five-years follow up. GPR15 gene expression was upregulated in smokers (beta (ß) = −2.699, p-value (p) = 1.02 × 10−77) and strongly correlated with smoking exposure (ß = −0.063, p = 2.95 × 10−34). Smoking cessation within five years reduced GPR15 expression about 19% (p = 9.65 × 10−5) with decreasing GPR15 expression over time (ß = 0.031, p = 3.81 × 10−6). Additionally, three novel CpG sites within GPR15 affected by smoking were identified. For CpG3.98251047, DNA methylation increased steadily after smoking cessation (ß = 0.123, p = 1.67 × 10−3) and strongly correlated with changes in GPR15 expression (ß = 0.036, p = 4.86 × 10−5). Three novel GPR15 CpG sites were identified in relation to smoking and GPR15 expression. Our results provide novel insights in the regulation of GPR15, which possibly linked smoking to inflammation and disease progression.